Targeting claudin-4 in human pancreatic cancer

Expert Opinion on Therapeutic Targets

Volumn 16, Issue 9, 2012, Pages 881-887

  Kojima, Takashi ^a   Kyuno, Daisuke ^a   Sawada, Norimasa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Claudin 18; Claudin 4; Imaging; Normal human pancreatic duct epithelial cells; Pancreatic cancer cells; Therapy

Indexed keywords

CLAUDIN 18; CLAUDIN 4; ENTEROTOXIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROTEIN KINASE C ALPHA; PROTEIN KINASE C ALPHA INHIBITOR; SMAD1 PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TROGLITAZONE;

CANCER CELL CULTURE; CLOSTRIDIUM PERFRINGENS; CYTOTOXICITY; DNA MICROARRAY; DRUG TARGETING; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOLECULAR IMAGING; MOLECULARLY TARGETED THERAPY; NONHUMAN; PANCREAS CANCER; PANCREAS DUCT; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

ANTINEOPLASTIC AGENTS; CLAUDIN-4; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS;

EID: 84865331988     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2012.708340     Document Type: Review

References (56)

1. Michl P, Barth C, Buchholz M, et al. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 2003;63(19):6265-71 (Pubitemid 37255173)
2. Morin PJ. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 2005;65(21):9603-6 (Pubitemid 41541431)
3. Karanjawala ZE, Illei PB, Ashfaq R, et al. New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. Am J Surg Pathol 2008;32(2):188-96 (Pubitemid 351172132)
4. Gumbiner BM. Breaking through the tight junction barrier. J Cell Biol 1993;123(6 Pt 2):1631-3 (Pubitemid 24012920)
5. Schneeberger EE, Lynch RD. Structure, function, and regulation of cellular tight junctions. Am J Physiol 1992; 262(6 Pt 1):L647-61
6. van Meer G, Simons K. The function of tight junctions in maintaining differences in lipid composition between the apical and the basolateral cell surface domains of MDCK cells. EMBO J 1986; 5(7):1455-64
7. Cereijido M, Valdes J, Shoshani L, et al. Role of tight junctions in establishing and maintaining cell polarity. Annu Rev Physiol 1998;60: 161-77 (Pubitemid 28157869)
8. Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol 2003;4(3):225-36 (Pubitemid 36288044)
9. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004;286(6):C1213-28 (Pubitemid 38649971)
10. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001;2(4):285-93 (Pubitemid 33676971)
11. Sawada N, Murata M, Kikuchi K, et al. Tight junctions and human diseases. Med Electron Microsc 2003; 36(3):147-56 (Pubitemid 37288275)
12. Ikenouchi J, Furuse M, Furuse K, et al. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 2005;171(6):939-45 (Pubitemid 41815826)
13. Gonzalez-Mariscal L, Tapia R, Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 2008;1778(3):729-56 (Pubitemid 351317800)
14. Kojima T, Murata M, Yamamoto T, et al. Tight junction proteins and signal transduction pathways in hepatocytes. Histol Histopathol 2009;24(11):1463-72
15. Meredith LW, Wilson GK, Fletcher NF, et al. Hepatitis C virus entry: beyond receptors. Rev Med Virol 2012;22(3):182-93
16. Krug SM, Gunzel D, Conrad MP, et al. Charge-selective claudin channels. Ann NY Acad Sci 2012;1257(1):20-8
17. Fujita K, Katahira J, Horiguchi Y, et al. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 2000;476(3):258-61 (Pubitemid 30410828)
18. McClane BA, Chakrabarti G. New insights into the cytotoxic mechanisms of clostridium perfringens enterotoxin. Anaerobe 2004;10(2):107-14 (Pubitemid 38519811)
19. Michl P, Buchholz M, Rolke M, et al. Claudin-4: a new target for pancreatic cancer treatment using clostridium perfringens enterotoxin. Gastroenterology 2001;121(3):678-84 (Pubitemid 32822583)
20. Sahin U, Koslowski M, Dhaene K, et al. Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development. Clin Cancer Res 2008;14(23):7624-34
21. Suzuki M, Kato-Nakano M, Kawamoto S, et al. Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers. Cancer Sci 2009;100(9):1623-30
22. Katahira J, Sugiyama H, Inoue N, et al. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem 1997;272(42):26652-8 (Pubitemid 27458889)
23. Saeki R, Kondoh M, Kakutani H, et al. A novel tumor-targeted therapy using a claudin-4-targeting molecule. Mol Pharmacol 2009;76(4):918-26
24. Neesse A, Griesmann H, Gress TM, et al. Claudin-4 as therapeutic target in cancer. Arch Biochem Biophys 2012; PubMed: 22286027
25. Sato N, Fukushima N, Maitra A, et al. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol 2004; 164(3):903-14 (Pubitemid 38235472)
26. Lee JH, Kim KS, Kim TJ, et al. Immunohistochemical analysis of claudin expression in pancreatic cystic tumors. Oncol Rep 2011;25(4):971-8
27. Tsutsumi K, Sato N, Tanabe R, et al. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. Ann Surg Oncol 2011; PubMed: 21837532
28. Tanaka M, Shibahara J, Fukushima N, et al. Claudin-18 is an early-stage marker of pancreatic carcinogenesis. J Histochem Cytochem 2011;59(10):942-52
29. Ito T, Kojima T, Yamaguchi H, et al. Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells. J Cell Biochem 2011;112(7): 1761-72
30. Soini Y, Takasawa A, Eskelinen M, et al. Expression of claudins 7 and 18 in pancreatic ductal adenocarcinoma: association with features of differentiation. J Clin Pathol 2012;65(5):431-6
31. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279(5349):349- 52 (Pubitemid 28063364)
32. Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998;8(5):279-82 (Pubitemid 28111458)
33. Yamaguchi H, Kojima T, Ito T, et al. Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells. Am J Pathol 2010;177(2):698-712
34. Kojima T, Takasawa A, Kyuno D, et al. Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells. Exp Cell Res 2011;317(16):2288-98
35. Balda MS, Gonzalez-Mariscal L, Matter K, et al. Assembly of the tight junction: the role of diacylglycerol. J Cell Biol 1993;123(2):293-302 (Pubitemid 23313955)
36. Andreeva AY, Piontek J, Blasig IE, et al. Assembly of tight junction is regulated by the antagonism of conventional and novel protein kinase C isoforms. Int J Biochem Cell Biol 2006;38(2):222-33 (Pubitemid 41619451)
37. Ellis B, Schneeberger EE, Rabito CA. Cellular variability in the development of tight junctions after activation of protein kinase C. Am J Physiol 1992;263(2 Pt 2):F293-300
38. Sjo A, Magnusson KE, Peterson KH. Distinct effects of protein kinase C on the barrier function at different developmental stages. Biosci Rep 2003;23(2-3):87-102 (Pubitemid 37222713)
39. Kyuno D, Kojima T, Ito T, et al. Protein kinase Calpha inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4. Cell Tissue Res 2011;346(3):369-81
40. Kumei S, Motomura W, Yoshizaki T, et al. Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells. Biochem Biophys Res Commun 2009;380(3):614-19
41. Yamaguchi H, Kojima T, Ito T, et al. Effects of clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cells. Cell Mol Biol Lett 2011;16(3):385-97
42. Deer EL, Gonzalez-Hernandez J, Coursen JD, et al. Phenotype and genotype of pancreatic cancer cell lines. Pancreas 2010;39(4):425-35
43. Tsukita S, Yamazaki Y, Katsuno T, et al. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 2008;27(55):6930-8
44. Rangel LB, Agarwal R, D'Souza T, et al. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 2003;9(7):2567-75 (Pubitemid 36842098)
45. Boylan KL, Misemer B, Derycke MS, et al. Claudin 4 is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation. Int J Mol Sci 2011;12(2):1334-58
46. Ogawa M, Kojima T, Someya M, et al. Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines. Histochem Cell Biol 2012; PubMed: 22544349
47. Ahmed N, Maines-Bandiera S, Quinn MA, et al. Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 2006;290(6):C1532-42 (Pubitemid 43830793)
48. Long H, Crean CD, Lee WH, et al. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 2001;61(21):7878-81 (Pubitemid 33049378)
49. Maeda T, Murata M, Chiba H, et al. Claudin-4-targeted therapy using clostridium perfringens enterotoxin for prostate cancer. Prostate 2012; 72(4):351-60
50. Sonoda N, Furuse M, Sasaki H, et al. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 1999;147(1):195-204 (Pubitemid 30211807)
51. Gao Z, Xu X, McClane B, et al. C terminus of clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to taxol and carboplatin. Clin Cancer Res 2011; 17(5):1065-74
52. Cocco E, Casagrande F, Bellone S, et al. Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer. BMC Cancer 2010;10:349
53. Yong KT. Anti-claudin-4-conjugated highly luminescent nanoparticles as biological labels for pancreatic cancer sensing. Methods Mol Biol 2011;762:427-38
54. Saeki R, Kondoh M, Kakutani H, et al. A claudin-targeting molecule as an inhibitor of tumor metastasis. J Pharmacol Exp Ther 2010;334(2):576-82
55. Kakutani H, Kondoh M, Saeki R, et al. Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin. Eur J Pharm Biopharm 2010;75(2):213-17
56. Takahashi A, Saito Y, Kondoh M, et al. Creation and biochemical analysis of a broad-specific claudin binder. Biomaterials 2012;33(12):3464-74